Prospective Iterative Trial of Proteasome Inhibitor-Based Desensitization-Reference-Cited by-同舟云学术

Prospective Iterative Trial of Proteasome Inhibitor-Based Desensitization

Published:2014-12-22 Issue:1 Volume:15 Page:101-118
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Woodle E. S.¹,Shields A. R.¹²,Ejaz N. S.¹,Sadaka B.¹,Girnita A.³,Walsh R. C.¹,Alloway R. R.⁴,Brailey P.³,Cardi M. A.²,Abu Jawdeh B. G.⁴,Roy-Chaudhury P.⁴,Govil A.⁴,Mogilishetty G.⁴

Affiliation:

1. Department of Surgery; Division of Transplantation; University of Cincinnati College of Medicine; Cincinnati OH

2. The Christ Hospital; Cincinnati OH

3. Transplant Immunology Division; Hoxworth Blood Center; Cincinnati OH

4. Department of Internal Medicine; Division of Nephrology; University of Cincinnati College of Medicine; Cincinnati OH

Funder

Millennium

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference23 articles.

1. OPTN/SRTR 2011; Annual Data Report: Kidney;Matas;Am J Transplant,2013

2. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation;Vo;Transplantation,2010

3. Overcoming a positive crossmatch in living-donor kidney transplantation;Gloor;Am J Transplant,2003

4. Living donor kidney transplantation across positive crossmatch: The University of Illinois at Chicago experience;Thielke;Transplantation,2009

5. Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients;Alachkar;Transplantation,2012

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imlifidase in Highly Sensitized Kidney Transplant Recipients With a Positive Crossmatch Against a Deceased Donor;Kidney International Reports;2024-07

2. Desensitization of Highly Immunized Kidney Transplant Recipients Awaiting Transplantation—Polish Single-Center Experience;Transplantation Proceedings;2024-05

3. Assessment of Novel Therapeutics to Improve Access to Transplantation for Highly Sensitized Patients in a Shifting Clinical Landscape;Journal of the American Society of Nephrology;2024-03

4. Management of the sensitized pediatric renal transplant candidate;Pediatric Transplantation;2024-02-24

5. Imlifidase Desensitization in HLA-incompatible Kidney Transplantation: Finding the Sweet Spot;Transplantation;2024-01-19